Foy A, O'Connell D, Henry D, Kelly J, Cocking S, Halliday J
Royal Newcastle Hospital, New South Wales, Australia.
J Gerontol A Biol Sci Med Sci. 1995 Mar;50(2):M99-106. doi: 10.1093/gerona/50a.2.m99.
Benzodiazepine drugs are used very frequently by the elderly and have been associated with a number of untoward events in them. In an earlier publication, we showed that there was an association between benzodiazepine use and episodes of confusion in hospital. The purpose of this study was to examine that association in more detail by studying only patients with intact cognitive function on admission and by taking into consideration a range of demographic, drug use, and clinical confounders.
A prospective cohort study was carried out of inpatients who had normal cognitive function on admission to hospital. The subjects were 418 hospital inpatients who had a normal result of a Mini-Mental State Examination (MMSE) performed within 24 hours of admission. They were aged 59-88 years. A clinical history and detailed drug use history were taken on admission and then the patients were followed prospectively for 10 days or until discharge, whichever was sooner. The MMSE was repeated every 2 days and all significant clinical events and episodes of delirium noted.
10.8% (95% Confidence Interval [CI]: 7.8-13.8%) of patients developed cognitive impairment (as indicated by a decrease in the MMSE). Factors that were statistically significantly related to the development of cognitive impairment included admission diagnoses of cancer or central nervous system (CNS) disease, alcohol consumption > 40 gms/day, hypoxia, and presence of benzodiazepines in the urine on admission. After adjusting for age, alcohol consumption, and admission diagnoses, those who reported taking benzodiazepines in daily doses equivalent to 5 mg or more of diazepam were at significantly higher risk of cognitive impairment than those who had not taken benzodiazepines (adjusted odds ratio = 3.5; 95% CI: 1.4-8.8). Twenty-one (5.0%, 95% CI: 2.9-7.1%) patients developed delirium as defined by the DSM-IIIR criteria. Age and hypoxia were statistically significantly related to the development of delirium. Due to the small number of cases of delirium, the power of the study to detect significant associations was low.
Elderly hospital inpatients who have intact cognitive function on admission to hospital have a low risk of developing cognitive impairment and delirium during their hospital stay. In this population, however, benzodiazepine use accounted for 29% of cases of cognitive impairment which did occur. The data also suggest that dehydration, urinary retention, and an admission diagnosis of CNS disease may be important risk factors for delirium.
苯二氮䓬类药物在老年人中使用非常频繁,且与他们身上的一些不良事件有关。在早期的一篇出版物中,我们表明苯二氮䓬类药物的使用与住院期间的意识混乱发作之间存在关联。本研究的目的是通过仅研究入院时认知功能完好的患者,并考虑一系列人口统计学、药物使用和临床混杂因素,来更详细地研究这种关联。
对入院时认知功能正常的住院患者进行了一项前瞻性队列研究。研究对象为418名住院患者,他们在入院后24小时内进行的简易精神状态检查表(MMSE)结果正常。他们的年龄在59 - 88岁之间。入院时记录了临床病史和详细的药物使用史,然后对患者进行前瞻性随访10天或直至出院,以时间较早者为准。每2天重复进行MMSE检查,并记录所有重大临床事件和谵妄发作情况。
10.8%(95%置信区间[CI]:7.8 - 13.8%)的患者出现了认知障碍(以MMSE评分下降表示)。与认知障碍发生在统计学上显著相关的因素包括癌症或中枢神经系统(CNS)疾病的入院诊断、每日酒精摄入量>40克、低氧以及入院时尿液中存在苯二氮䓬类药物。在对年龄、酒精摄入量和入院诊断进行调整后,那些报告每日服用相当于5毫克或更多地西泮剂量的苯二氮䓬类药物的患者,发生认知障碍的风险显著高于未服用苯二氮䓬类药物的患者(调整后的优势比 = 3.5;95% CI:1.4 - 8.8)。21名(5.0%,95% CI:2.9 - 7.1%)患者出现了符合《精神疾病诊断与统计手册》第三版修订本(DSM-IIIR)标准定义的谵妄。年龄和低氧与谵妄的发生在统计学上显著相关。由于谵妄病例数量较少,该研究检测显著关联的能力较低。
入院时认知功能完好的老年住院患者在住院期间发生认知障碍和谵妄的风险较低。然而,在这一人群中,发生的认知障碍病例中有29%是由苯二氮䓬类药物的使用所致。数据还表明,脱水、尿潴留和CNS疾病的入院诊断可能是谵妄的重要危险因素。